Starton Therapeutics (Starton Therapeutics) Price-to-Tangible-Book : (As of Jun. 08, 2024)

View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Price-to-Tangible-Book?

As of today (2024-06-08), Starton Therapeutics's share price is $0.00. Starton Therapeutics's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was $-0.15. Hence, Starton Therapeutics's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Starton Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

STA's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.77
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Starton Therapeutics's share price is $0.00. Starton Therapeutics's Book Value per Sharefor the quarter that ended in Jun. 2023 was $-0.14. Hence, Starton Therapeutics's P/B Ratio of today is .

Starton Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Starton Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Price-to-Tangible-Book Chart

Starton Therapeutics Annual Data

Trend

Mar21

Mar22

Mar23

Price-to-Tangible-Book

Starton Therapeutics Quarterly Data
	Mar21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23
Price-to-Tangible-Book	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Starton Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Starton Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Starton Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Starton Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Starton Therapeutics's Price-to-Tangible-Book falls into.

Starton Therapeutics Price-to-Tangible-Book Calculation

Starton Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	0.00	/	-0.147
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Starton Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Starton Therapeutics (Starton Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

215 College Road, Suite No.300, Paramus, NJ, USA, 07652

Website

https://www.startontx.com

Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines